Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Reviews in the Neurosciences

Editor-in-Chief: Huston, Joseph P.

Editorial Board: Topic, Bianca / Adeli, Hojjat / Buzsaki, Gyorgy / Crawley, Jacqueline / Crow, Tim / Gold, Paul / Holsboer, Florian / Korth, Carsten / Li, Jay-Shake / Lubec, Gert / McEwen, Bruce / Pan, Weihong / Pletnikov, Mikhail / Robbins, Trevor / Schnitzler, Alfons / Stevens, Charles / Steward, Oswald / Trojanowski, John

IMPACT FACTOR 2017: 2.590
5-year IMPACT FACTOR: 3.078

CiteScore 2017: 2.81

SCImago Journal Rank (SJR) 2017: 0.980
Source Normalized Impact per Paper (SNIP) 2017: 0.804

See all formats and pricing
More options …
Volume 29, Issue 7


Neurological and psychiatric disorders in psoriasis

Man Amanat
  • NeuroImmunology Research Association (NIRA), Universal Scientific Education and Research Network (USERN), Tehran 14194, Iran
  • Students’ Scientific Research Center, Tehran University of Medical Sciences, Tehran 1417755331, Iran
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Mona Salehi
  • NeuroImmunology Research Association (NIRA), Universal Scientific Education and Research Network (USERN), Tehran 14194, Iran
  • Students’ Scientific Research Center, Tehran University of Medical Sciences, Tehran 1417755331, Iran
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Nima Rezaei
  • Corresponding author
  • Research Center for Immunodeficiencies, Children’s Medical Center, Tehran University of Medical Sciences, Dr. Gharib St, Keshavarz Blvd, Tehran 14194, Iran
  • Department of Immunology and Biology, School of Medicine, Tehran University of Medical Sciences, Tehran 14155-6447, Iran
  • Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Boston, MA 1419733151, USA
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2018-03-06 | DOI: https://doi.org/10.1515/revneuro-2017-0108


Psoriasis used to be known as a skin disorder; however, it can now be considered as a systemic disease with the involvement of multiple organs. Neurological and psychiatric disorders are some of the associated problems that can be observed in patients with psoriasis. Stroke, multiple sclerosis, seizure, migraine, restless leg syndrome, Parkinson’s disease, Guillain-Barré syndrome, and myasthenia gravis are the reported neurological diseases, while depression, bipolar mood disorder, anxiety, psychosis, cognitive impairment, personality disorders, sexual disorders, sleep disturbance, and eating disorders are the recognized psychiatric presentations in patients with psoriasis. Herein, the neurological and psychiatric disorders of psoriasis are described.

Keywords: anxiety; depression; migraine; multiple sclerosis; myasthenia gravis; Parkinson’s disease; psoriasis; psychosis; seizure; stroke


  • Abuabara, K., Azfar, R.S., Shin, D.B., Neimann, A.L., Troxel, A.B., and Gelfand, J.M. (2010). Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the UK. Br. J. Dermatol. 163, 586–592.CrossrefGoogle Scholar

  • Aleem, D. and Tohid, H. (2017). Pro-inflammatory cytokines, biomarkers, genetics and the immune system: a mechanistic approach of depression and psoriasis. Rev. Colomb. Psiquiatr. 47. doi:10.1016/j.rcp.2017.03.002.PubMedGoogle Scholar

  • Baxter, A.J., Scott, K.M., Vos, T., and Whiteford, H.A. (2013). Global prevalence of anxiety disorders: a systematic review and meta-regression. Psychol. Med. 43, 897–910.CrossrefPubMedGoogle Scholar

  • Benros, M.E., Nielsen, P.R., Nordentoft, M., Eaton, W.W., Dalton, S.O., and Mortensen, P.B. (2011). Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study. Am. J. Psychiatry 168, 1303–1310.CrossrefPubMedGoogle Scholar

  • Benros, M.E., Eaton, W.W., and Mortensen, P.B. (2014a). The epidemiologic evidence linking autoimmune diseases and psychosis. Biol. Psychiatry 75, 300–306.CrossrefGoogle Scholar

  • Benros, M.E., Pedersen, M.G., Rasmussen, H., Eaton, W.W., Nordentoft, M., and Mortensen, P.B. (2014b). A nationwide study on the risk of autoimmune diseases in individuals with a personal or a family history of schizophrenia and related psychosis. Am. J. Psychiatry 171, 218–226.CrossrefGoogle Scholar

  • Bilgic, A., Samanci-Karaman, N., Akman-karakaş, A., Yilmaz, E., and Alpsoy, E. (2013). Is restless legs syndrome associated with psoriasis? J. Eur. Acad. Dermatol. Venereol. 27, 71–72.Google Scholar

  • Bouguéon, K. and Misery, L. (2008). Depression and psoriasis. Ann. Dermatol. Venereol. 135, S254–S258.Google Scholar

  • Brand, C.A. and Littlejohn, G.O. (1984). Psoriatic arthritis and myasthenia gravis. J. Rheumatol. 11, 244.PubMedGoogle Scholar

  • Capo, A., Affaitati, G., Giamberardino, M.A., and Amerio, P. (2018). Psoriasis and migraine. J. Eur. Acad. Dermatol. Venereol. 32, 57–61.CrossrefPubMedGoogle Scholar

  • Chen, S.J., Chao, Y.L., Chen, C.Y., Chang, C.M., Wu, E.C.H., Wu, C.S., Yeh, H.H., Chen, C.H., and Tsai, H.J. (2012). Prevalence of autoimmune diseases in in-patients with schizophrenia: nationwide population-based study. Br. J. Psychiatry 200, 374–380.PubMedCrossrefGoogle Scholar

  • Chen, Y.J., Chen, C.C., Lin, M.W., Chen, T.J., Li, C.Y., Hwang, C.Y., Chu, S.Y., Lee, D.D., Chang, Y.T., Wang, W.J., et al. (2013). Increased risk of sexual dysfunction in male patients with psoriasis: a nationwide population-based follow-up study. J. Sex. Med. 10, 1212–1218.PubMedCrossrefGoogle Scholar

  • Chung, J., Takeshita, J., Shin, D.B., Haynes, K., Arnold, S.E., and Gelfand, J. (2015). The risk of Parkinson’s disease in patients with psoriasis: a population-based cohort study. J. Invest. Dermatol. 135, S53–S55.Google Scholar

  • Cicek, D., Halisdemir, N., Dertioglu, S.B., Berilgen, M.S., Ozel, S., and Colak, C. (2012). Increased frequency of restless legs syndrome in atopic dermatitis. Clin. Exp. Dermatol. 37, 469–476.CrossrefPubMedGoogle Scholar

  • Colgecen, E., Celikbilek, A., and Keskin, D.T. (2016). Cognitive impairment in patients with psoriasis: a cross-sectional study using the Montreal Cognitive Assessment. Am. J. Clin. Dermatol. 17, 413–419.PubMedCrossrefGoogle Scholar

  • Crosta, M.L., Caldarola, G., Fraietta, S., Craba, A., Benedetti, C., Coco, V., Janiri, L., Rinaldi, L. and De Simone, C. (2014). Psychopathology and eating disorders in patients with psoriasis. G. Ital. Dermatol. Venereol. 149, 355–361.PubMedGoogle Scholar

  • Demirhan, O., Demirbek, B., Tunç, E., Uslu, İ.N., Çetiner, S., and Serin, A. (2012). Identification of chromosome abnormalities in screening of a family with manic depression and psoriasis: predisposition to aneuploidy. Asian. J. Psychiatry 5, 169–174.CrossrefGoogle Scholar

  • Dowlatshahi, E.A., Wakkee, M., Arends, L.R., and Nijsten, T. (2014). The prevalence and odds of depressive symptoms and clinical depression in psoriasis patients: a systematic review and meta-analysis. J. Invest. Dermatol. 134, 1542–1551.PubMedCrossrefGoogle Scholar

  • Duffin, K.C., Wong, B., and Krueger, G. (2009). Sleep disturbance and medical comorbidities in patients with psoriasis, psoriatic arthritis, and controls. J. Am. Acad. Dermatol. 60, AB9.Google Scholar

  • Eaton, W.W., Byrne, M., Ewald, H., Mors, O., Chen, C.Y., Agerbo, E., and Mortensen, P.B. (2006). Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am. J. Psychiatry 163, 521–528.CrossrefPubMedGoogle Scholar

  • Eaton, W.W., Pedersen, M.G., Nielsen, P.R., and Mortensen, P.B. (2010). Autoimmune diseases, bipolar disorder, and non-affective psychosis. Bipolar Disord. 12, 638–646.PubMedCrossrefGoogle Scholar

  • Egeberg, A., Khalid, U., Gislason, G.H., Mallbris, L., Skov, L., and Hansen, P.R. (2015a). Association between depression and risk of atrial fibrillation and stroke in patients with psoriasis: a Danish nationwide cohort study. Br. J. Dermatol. 173, 471–479.CrossrefGoogle Scholar

  • Egeberg, A., Mallbris, L., Gislason, G.H., Skov, L., and Hansen, P.R. (2015b). Increased risk of migraine in patients with psoriasis: a Danish nationwide cohort study. J. Am. Acad. Dermatol. 73, 829–835.CrossrefGoogle Scholar

  • Egeberg, A., Khalid, U., Gislason, G.H., Mallbris, L., Skov, L., and Hansen, P.R. (2016a). Psoriasis and sleep apnea: a Danish nationwide cohort study. J. Clin. Sleep. Med. 12, 663–671.CrossrefGoogle Scholar

  • Egeberg, A., Khalid, U., Hilmar Gislason, G., Mallbris, L., Skov, L., and Riis Hansen, P. (2016b). Impact of depression on risk of myocardial infarction, stroke and cardiovascular death in patients with psoriasis: a Danish nationwide study. Acta Derm. Venereol. 96, 218–222.CrossrefGoogle Scholar

  • Egeberg, A., Mallbris, L., Gislason, G.H., Skov, L., and Hansen, P.R. (2016c). Risk of multiple sclerosis in patients with psoriasis: a Danish nationwide cohort study. J. Invest. Dermatol. 136, 93–98.CrossrefGoogle Scholar

  • Fagius, J., Osterman, P.O., Siden, A., and Wiholm, B.E. (1985). Guillain-Barré syndrome following zimeldine treatment. J. Neurol. Neurosurg. Psychiatry 48, 65–69.PubMedCrossrefGoogle Scholar

  • Feldman, S.R., Tian, H., Gilloteau, I., Mollon, P., and Shu, M. (2017). Economic burden of comorbidities in psoriasis patients in the United States: results from a retrospective US database. BMC Health Serv. Res. 17, 337.CrossrefGoogle Scholar

  • Ferreira, B.I., Abreu, J.L., Reis, J.P., and Figueiredo, A.M. (2016). Psoriasis and associated psychiatric disorders: a systematic review on etiopathogenesis and clinical correlation. J. Clin. Aesthet. Dermatol. 9, 36–43.PubMedGoogle Scholar

  • Fleming, P., Kraft, J., Gulliver, W.P., and Lynde, C. (2015). The relationship of obesity with the severity of psoriasis: a systematic review. J. Cutan. Med. Surg. 19, 450–456.CrossrefPubMedGoogle Scholar

  • Fleming, P., Bai, J.W., Pratt, M., Sibbald, C., Lynde, C., and Gulliver, W.P. (2017). The prevalence of anxiety in patients with psoriasis: a systematic review of observational studies and clinical trials. J. Eur. Acad. Dermatol. Venereol. 31, 798–807.CrossrefPubMedGoogle Scholar

  • Gadzia, J. and Turner, J. (2010). Progressive multifocal leukoencephalopathy in two psoriasis patients treated with efalizumab. J. Drugs Dermatol. 9, 1005–1009.PubMedGoogle Scholar

  • Galili, E., Barzilai, A., Shreberk-Hassidim, R., Merdler, I., Caspi, T., and Astman, N. (2017). Neuropsychiatric comorbidity among adolescents with psoriasis. Br. J. Dermatol. Published online ahead of print, February 4, 2018.Google Scholar

  • Gelfand, J.M., Dommasch, E.D., Shin, D.B., Azfar, R.S., Kurd, S.K., Wang, X., and Troxel, A.B. (2009). The risk of stroke in patients with psoriasis. J. Invest. Dermatol. 129, 2411–2418.PubMedCrossrefGoogle Scholar

  • Gerdes, S., Zahl, V.A., Knopf, H., Weichenthal, M., and Mrowietz, U. (2008). Comedication related to comorbidities: a study in 1203 hospitalized patients with severe psoriasis. Br. J. Dermatol. 159, 1116–1123.PubMedGoogle Scholar

  • Gisondi, P., Sala, F., Alessandrini, F., Avesani, V., Zoccatelli, G., Beltramello, A., Moretto, G., Gambina, G., and Girolomoni, G. (2014). Mild cognitive impairment in patients with moderate to severe chronic plaque psoriasis. Dermatology 228, 78–85.PubMedCrossrefGoogle Scholar

  • Gowda, S., Goldblum, O.M., McCall, W.V., and Feldman, S.R. (2010). Factors affecting sleep quality in patients with psoriasis. J. Am. Acad. Dermatol. 63, 114–123.CrossrefPubMedGoogle Scholar

  • Guido, N., Cices, A., Ibler, E., Huynh, T., Majewski, S., Sable, K., Rangel, S.M., West, D.P., Laumann, A.E., and Nardone, B. (2017). Multiple sclerosis association with psoriasis: a large US population, single centre, retrospective cross-sectional study. J. Eur. Acad. Dermatol. Venereol. 31, e397–e398.CrossrefGoogle Scholar

  • Gupta, M.A. and Gupta, A.K. (1997). Psoriasis and sex: a study of moderately to severely affected patients. Int. J. Dermatol. 36, 259–262.CrossrefPubMedGoogle Scholar

  • Gupta, M.A., Simpson, F.C., and Gupta, A.K. (2016). Psoriasis and sleep disorders: a systematic review. Sleep Med. Rev. 29, 63–75.PubMedCrossrefGoogle Scholar

  • Harden, J.L., Krueger, J.G., and Bowcock, A.M. (2015). The immunogenetics of psoriasis: a comprehensive review. J. Autoimmun. 64, 66–73.PubMedCrossrefGoogle Scholar

  • Jensen, P., Ahlehoff, O., Egeberg, A., Gislason, G., Hansen, P.R., and Skov, L. (2016). Psoriasis and new-onset depression: a Danish nationwide cohort study. Acta Derm. Venereol. 96, 39–42.PubMedCrossrefGoogle Scholar

  • Jensen, P., Egeberg, A., Gislason, G., Thyssen, J.P., and Skov, L. (2017). Risk of uncommon cancers in patients with psoriasis: a Danish nationwide cohort study. J. Eur. Acad. Dermatol. Venereol. Published online ahead of print, October 24, 2017.Google Scholar

  • Ji, S., Zang, Z., Ma, H., Gu, M., Han, Y., Wang, L., Jia, S., and Yang, B. (2016). Erectile dysfunction in patients with plaque psoriasis: the relation of depression and cardiovascular factors. Int. J. Impot. Res. 28, 96–100.CrossrefPubMedGoogle Scholar

  • Karaca, S., Fidan, F., Erkan, F., Nural, S., Pinarcı, T., Gunay, E., and Unlu, M. (2013). Might psoriasis be a risk factor for obstructive sleep apnea syndrome? Sleep Breath. 17, 275–280.CrossrefPubMedGoogle Scholar

  • Kelati, A., Baybay, H., Najdi, A., Zinoune, S., and Mernissi, F.Z. (2017). Pediatric psoriasis: should we be concerned with comorbidities? A cross sectional study. Pediatr. Int. 59, 923–928.PubMedCrossrefGoogle Scholar

  • Kimball, A.B., Wu, E.Q., Guérin, A., Andrew, P.Y., Tsaneva, M., Gupta, S.R., Bao, Y., and Mulani, P.M. (2012). Risks of developing psychiatric disorders in pediatric patients with psoriasis. J. Am. Acad. Dermatol. 67, 651–657.CrossrefPubMedGoogle Scholar

  • Koc, F. and Yerdelen, D. (2009). Myasthenia gravis and psoriasis vulgaris. Neurosciences (Riyadh) 14, 175–177.PubMedGoogle Scholar

  • Koo, J., Marangell, L.B., Nakamura, M., Armstrong, A., Jeon, C., Bhutani, T., and Wu, J.J. (2017). Depression and suicidality in psoriasis: review of the literature including the cytokine theory of depression. J. Eur. Acad. Dermatol. Venereol. 31, 1999–2009.PubMedCrossrefGoogle Scholar

  • Korkoliakou, P., Christodoulou, C., Kouris, A., Porichi, E., Efstathiou, V., Kaloudi, E., Kokkevi, A., Stavrianeas, N., Papageorgiou, C., and Douzenis, A. (2014). Alexithymia, anxiety and depression in patients with psoriasis: a case–control study. Ann. Gen. Psychiatry. 13, 38.PubMedCrossrefGoogle Scholar

  • Kumar, S., Kachhawha, D., Koolwal, G.D., Gehlot, S., and Awasthi, A. (2011). Psychiatric morbidity in psoriasis patients: a pilot study. Indian. J. Dermatol. Venereol. Leprol. 77, 625.CrossrefPubMedGoogle Scholar

  • Kumar, V., Mattoo, S.K., and Handa, S. (2013). Psychiatric morbidity in pemphigus and psoriasis: a comparative study from India. Asian J. Psychiatr. 6, 151–156.CrossrefPubMedGoogle Scholar

  • Kurd, S.K., Troxel, A.B., Crits-Christoph, P., and Gelfand, J.M. (2010). The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. Arch. Dermatol. 146, 891–895.PubMedGoogle Scholar

  • Kwan, S.Y., Lin, J.H., and Su, M.S. (2000). Coexistence of epilepsy, myasthenia gravis and psoriasis vulgaris. Zhonghua Yi Xue Za Zhi (Taipei) 63, 153–157.PubMedGoogle Scholar

  • Lakshmy, S., Balasundaram, S., Sarkar, S., Audhya, M., and Subramaniam, E. (2015). A cross-sectional study of prevalence and implications of depression and anxiety in psoriasis. Indian J. Psychol. Med. 37, 434–440.CrossrefPubMedGoogle Scholar

  • Le, H., Tfelt-Hansen, P., Russell, M.B., Skytthe, A., Kyvik, K.O., and Olesen, J. (2011). Co-morbidity of migraine with somatic disease in a large population-based study. Cephalalgia 31, 43–64.CrossrefGoogle Scholar

  • Lee, M.S., Yeh, Y.C., Chang, Y.T., and Lai, M.S. (2017). All-cause and cause-specific mortality in patients with psoriasis in Taiwan: a nationwide population-based study. J. Invest. Dermatol. 137, 1468–1473.CrossrefPubMedGoogle Scholar

  • Li, X., Sundquist, J., and Sundquist, K. (2012). Subsequent risks of Parkinson disease in patients with autoimmune and related disorders: a nationwide epidemiological study from Sweden. Neurodegener. Dis. 10, 277–284.PubMedCrossrefGoogle Scholar

  • Lindegård, B. (1986). Diseases associated with psoriasis in a general population of 159,200 middle-aged, urban, native Swedes. Dermatologica 172, 298–304.CrossrefGoogle Scholar

  • Machado-Pinto, J., Diniz, M.D., and Bavoso, N.C. (2016). Psoriasis: new comorbidities. Ann. Bras. Dermatol. 91, 8–14.CrossrefGoogle Scholar

  • Marek-Józefowicz, L., Jaracz, M., Placek, W., Czajkowski, R., and Borkowska, A. (2017). Cognitive impairment in patients with severe psoriasis. Postepy. Dermatol. Alergol. 34, 120–125.PubMedGoogle Scholar

  • Marin, S.G., García, I.D.H., Pedrosa, N.M., García, M.O., and Garnica, V.M. (2017). Psychosis and psoriasis, the skin talks the truth. Eur. Psychiatry 41, S812.CrossrefGoogle Scholar

  • Marrie, R.A., Patten, S.B., Tremlett, H., Wolfson, C., Leung, S., and Fisk, J.D. (2017). Increased incidence and prevalence of psoriasis in multiple sclerosis. Mult. Scler. Relat. Disord. 13, 81–86.CrossrefPubMedGoogle Scholar

  • Martínez-Orozco, F.J., Vicario, J.L., Villalibre-Valderrey, I., De Andrés, C., Fernández-Arquero, M., and Peraita-Adrados, R. (2014). Narcolepsy with cataplexy and comorbid immunopathological diseases. J. Sleep Res. 23, 414–419.PubMedCrossrefGoogle Scholar

  • Matusiewicz, D., Koerber, A., Schadendorf, D., Wasem, J., and Neumann, A. (2014). Childhood psoriasis—an analysis of German health insurance data. Pediatr. Dermatol. 31, 8–13.CrossrefGoogle Scholar

  • Mazzetti, M., Mozzetta, A., Soavi, G.C., Andreoli, E., Foglio, B.P., Puddu, P., and Decaminada, F. (1994). Psoriasis, stress and psychiatry: psychodynamic characteristics of stressors. Acta. Derm. Venereol. Suppl. (Stockholm) 186, 62–64.Google Scholar

  • McDonough, E., Ayearst, R., Eder, L., Chandran, V., Rosen, C.F., Thavaneswaran, A., and Gladman, D.D. (2014). Depression and anxiety in psoriatic disease: prevalence and associated factors. J. Rheumatol. 41, 887–896.CrossrefPubMedGoogle Scholar

  • Metz, I., Traffehn, S., Straßburger-Krogias, K., Keyvani, K., Bergmann, M., Nolte, K., Weber, M.S., Bartsch, T., Gold, R., and Brück, W. (2015). Glial cells express nuclear Nrf2 after fumarate treatment for multiple sclerosis and psoriasis. Neurol. Neuroimmunol. Neuroinflamm. 2, e99.CrossrefPubMedGoogle Scholar

  • Miron, G., Gurevich, M., Baum, S., Achiron, A., and Barzilai, A. (2017). Psoriasis comorbidity affects multiple sclerosis neurological progression: a retrospective case–control analysis. J. Eur. Acad. Dermatol. Venereol. 31, 2055–2061.PubMedCrossrefGoogle Scholar

  • Molina-Leyva, A., Jiménez-Moleón, J.J., Naranjo-Sintes, R., and Ruiz-Carrascosa, J.C. (2015). Sexual dysfunction in psoriasis: a systematic review. J. Eur. Acad. Dermatol. Venereol. 29, 649–655.PubMedCrossrefGoogle Scholar

  • Muth, C.C. (2017). Restless legs syndrome. J. Am. Med. Assoc. 317, 780.CrossrefGoogle Scholar

  • Nakao, M., Asano, Y., Nakamura, K., Shida, R., Takahashi, T., Yoshizaki, A., Mitsui, A., Shibata, S., Araki, M., Watanabe, R., et al. (2016). The development of chronic inflammatory demyelinating polyneuropathy during adalimumab treatment in a patient with psoriasis vulgaris. Eur. J. Dermatol. 26, 404–405.Google Scholar

  • O’Donnell, M.J., Chin, S. L., Rangarajan, S., Xavier, D., Liu, L., Zhang, H., Rao-Melacini, P., Zhang, X., Pais, P., Agapay, S., et al. (2016). Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet 388, 761–775.PubMedCrossrefGoogle Scholar

  • Oka, A., Mabuchi, T., Ozawa, A., and Inoko, H. (2012). Current understanding of human genetics and genetic analysis of psoriasis. J. Dermatol. 39, 231–241.CrossrefPubMedGoogle Scholar

  • Ong, M.S., Kohane, I.S., Cai, T., Gorman, M.P., and Mandl, K.D. (2014). Population-level evidence for an autoimmune etiology of epilepsy. J. Am. Med. Assoc. Neurol. 71, 569–574.Google Scholar

  • Pupillo, E., Cricelli, C., Mazzoleni, F., Cricelli, I., Pasqua, A., Pecchioli, S., Lapi, F., and Beghi, E. (2016). Epidemiology of Parkinson’s disease: a population-based study in primary care in Italy. Neuroepidemiology 47, 38–45.CrossrefPubMedGoogle Scholar

  • Raaby, L., Ahlehoff, O., and de Thurah, A. (2017). Psoriasis and cardiovascular events: updating the evidence. Arch. Dermatol. Res. 309, 225–228.PubMedCrossrefGoogle Scholar

  • Rachakonda, T.D., Schupp, C.W., and Armstrong, A.W. (2014). Psoriasis prevalence among adults in the United States. J. Am. Acad. Dermatol. 70, 512–516.PubMedCrossrefGoogle Scholar

  • Remröd, C., Sjöström, K., and Svensson, Å. (2013). Psychological differences between early-and late-onset psoriasis: a study of personality traits, anxiety and depression in psoriasis. Br. J. Dermatol. 169, 344–350.CrossrefPubMedGoogle Scholar

  • Rubino, I.A. and Zanna, V. (1996). Further comments on psoriasis and personality disorders. Psychol. Rep. 79, 1248–1250.CrossrefPubMedGoogle Scholar

  • Rugbjerg, K., Friis, S., Ritz, B., Schernhammer, E.S., Korbo, L., and Olsen, J.H. (2009). Autoimmune disease and risk for Parkinson disease: a population-based case-control study. Neurology 73, 1462–1468.PubMedCrossrefGoogle Scholar

  • Sampogna, F., Gisondi, P., Tabolli, S., and Abeni, D. (2007). Impairment of sexual life in patients with psoriasis. Dermatology 214, 144–150.PubMedCrossrefGoogle Scholar

  • Sargin, B. and Gürer, G. (2017). Psoriasis and Guillain-Barré syndrome: incidental or associated? Arch. Reumatol. 32, 273–274.Google Scholar

  • Sarkar, S., Sarkar, A., Saha, R., and Sarkar, T. (2014). Psoriasis and psychiatric morbidity: a profile from a tertiary care centre of Eastern India. J. Family Med. Prim. Care 3, 29–32.PubMedCrossrefGoogle Scholar

  • Schell, C., Schleich, R., Walker, F., Yazdi, A.S., Lerche, H., Röcken, M., Axmann, D., Ghoreschi, K., and Eberle, F.C. (2015). Restless legs syndrome in psoriasis: an unexpected comorbidity. Eur. J. Dermatol. 25, 255–260.PubMedGoogle Scholar

  • Sheu, J.J., Wang, K.H., Lin, H.C., and Huang, C.C. (2013). Psoriasis is associated with an increased risk of parkinsonism: a population-based 5-year follow-up study. J. Am. Acad. Dermatol. 68, 992–999.CrossrefPubMedGoogle Scholar

  • Shin, I.S., Baer, A.N., Kwon, H.J., Papadopoulos, E.J., and Siegel, J.N. (2006). Guillain-Barré and Miller Fisher syndromes occurring with tumor necrosis factor α antagonist therapy. Arthritis Rheumatol. 54, 1429–1434.CrossrefGoogle Scholar

  • Shivakumar, V., Agarwal, S.M., Bose, A., Kandasamy, A., Rao, N.P., Narayanaswamy, J.C., and Venkatasubramanian, G. (2016). Safety of transcranial direct current stimulation in alcohol-induced psychotic disorder with comorbid psoriasis. Indian J. Psychol. Med. 38, 71–73.CrossrefPubMedGoogle Scholar

  • Sifneos, P.E. (1973). The prevalence of ‘alexithymic’ characteristics in psychosomatic patients. Psychother. Psychosom. 22, 255–262.CrossrefPubMedGoogle Scholar

  • Sun, Y., Zhang, J., Zhai, T., Li, H., Li, H., Huo, R., Shen, B., Wang, B., Chen, X., Li, N., et al. (2017). CCN1 promotes IL-1β production in keratinocytes by activating p38 MAPK signaling in psoriasis. Sci. Rep. 7, 43310.PubMedCrossrefGoogle Scholar

  • Svedbom, A., Dalén, J., Mamolo, C., Cappelleri, J.C., Mallbris, L., Petersson, I.F., and Ståhle, M. (2015). Increased cause-specific mortality in patients with mild and severe psoriasis: a population-based Swedish register study. Acta Derm. Venereol. 95, 809–815.PubMedGoogle Scholar

  • Takahashi, H., Tsuji, H., and Iizuk, H. (2014). Three cases of psoriasis vulgaris associated with myasthenia gravis. J. Dermatol. 41, 462–463.PubMedCrossrefGoogle Scholar

  • Temel, A.B., Karaman, N.S., Bozkurt, S., Karakaş, A.A., Yılmaz, E., and Alpsoy, E. (2016). Prevalence of restless legs syndrome among psoriasis patients and association with depression and sleep quality. Turk. J. Dermatol. 10, 110–115.CrossrefGoogle Scholar

  • Todberg, T., Egeberg, A., Jensen, P., Gislason, G., and Skov, L. (2017). Psychiatric comorbidities in children and adolescents with psoriasis: a population-based cohort study. Br. J. Dermatol. 177, 551–553.CrossrefPubMedGoogle Scholar

  • Ungprasert, P., Srivali, N., and Kittanamongkolchai, W. (2016). Risk of Parkinson’s disease among patients with psoriasis: a systematic review and meta-analysis. Indian J. Dermatol. 61, 152.PubMedCrossrefGoogle Scholar

  • Villarejo, C., Fernández-Aranda, F., Jiménez-Murcia, S., Peñas-Lledó, E., Granero, R., Penelo, E., Tinahones, F.J., Sancho, C., Vilarrasa, N., Montserrat-Gil de Bernabé, M., et al. (2012). Lifetime obesity in patients with eating disorders: increasing prevalence, clinical and personality correlates. Eur. Eat. Disord. Rev. 20, 250–254.PubMedCrossrefGoogle Scholar

  • Yang, Y.W., Keller, J.J., and Lin, H.C. (2011). Medical comorbidity associated with psoriasis in adults: a population-based study. Br. J. Dermatol. 165, 1037–1043.CrossrefPubMedGoogle Scholar

About the article

Received: 2017-12-12

Accepted: 2018-01-26

Published Online: 2018-03-06

Published in Print: 2018-09-25

Citation Information: Reviews in the Neurosciences, Volume 29, Issue 7, Pages 805–813, ISSN (Online) 2191-0200, ISSN (Print) 0334-1763, DOI: https://doi.org/10.1515/revneuro-2017-0108.

Export Citation

©2018 Walter de Gruyter GmbH, Berlin/Boston.Get Permission

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

Man Amanat, Roland Thijs, Mona Salehi, and Josemir W. Sander
Seizure, 2018

Comments (0)

Please log in or register to comment.
Log in